Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Chu

Showing results (211-220 of 219) with videos related to

Pageof 22
Sort By:
You have reached the last page of results.This site can display upto 219 results.
European Urology|April 12, 2021
Prostate-specific Membrane Antigen and Fluciclovine Transporter Genes are Associated with Variable Clinical Features and Molecular Subtypes of Primary Prostate CancerCarissa E Chu, Mohammed Alshalalfa, Martin Sjöström, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 28, 2016
First-in-human phase I study of copanlisib (BAY 80-6946), an intravenous pan-class I phosphatidylinositol 3-kinase inhibitor, in patients with advanced solid tumors and non-Hodgkin's lymphomasA Patnaik, L J Appleman, A W Tolcher, et al.
The Oncologist|June 22, 2024
HER2 overexpression in urothelial carcinoma with GATA3 and PPARG copy number gainsXiaolin Zhu, Emily Chan, Michelle L Turski, et al.
Science (New York, N.Y.)|March 12, 2026
Autophagolysosomal exocytosis inverts Src kinase onto the cell surface in cancerCorleone S Delaveris, Rita P Loudermilk, Apurva Pandey, et al.
Cell Reports|December 21, 2022
Genomic heterogeneity as a barrier to precision oncology in urothelial cancerTimothy N Clinton, Ziyu Chen, Hannah Wise, et al.
Nature Communications|September 10, 2025
Modulating the PPARγ pathway upregulates NECTIN4 and enhances chimeric antigen receptor (CAR) T cell therapy in bladder cancerKevin Chang, Henry M Delavan, Elizabeth Yip, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 8, 2025
Impaired CAMK4 Activity Limits Atherosclerosis and Reprograms MyelopoiesisAzuah L Gonzalez, Cristina M Youwakim, Brenda F Leake, et al.
European Urology|April 27, 2025
Clinical Outcomes, Genomic Heterogeneity, and Therapeutic Considerations Across Histologic Subtypes of Urothelial CarcinomaCarissa E Chu, Ziyu Chen, Karissa Whiting, et al.
JCO Precision Oncology|May 1, 2024
Natural History and Genomic Landscape of Chemotherapy-Resistant Muscle-Invasive Bladder CancerAndrew T Lenis, Karissa Whiting, Vignesh Ravichandran, et al.
Pageof 22

Showing results (211-220 of 219) with videos related to

Sort By:
Pageof 22
You have reached the last page of results.This site can display upto 219 results.
European Urology|April 12, 2021
Prostate-specific Membrane Antigen and Fluciclovine Transporter Genes are Associated with Variable Clinical Features and Molecular Subtypes of Primary Prostate CancerCarissa E Chu, Mohammed Alshalalfa, Martin Sjöström, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 28, 2016
First-in-human phase I study of copanlisib (BAY 80-6946), an intravenous pan-class I phosphatidylinositol 3-kinase inhibitor, in patients with advanced solid tumors and non-Hodgkin's lymphomasA Patnaik, L J Appleman, A W Tolcher, et al.
The Oncologist|June 22, 2024
HER2 overexpression in urothelial carcinoma with GATA3 and PPARG copy number gainsXiaolin Zhu, Emily Chan, Michelle L Turski, et al.
Science (New York, N.Y.)|March 12, 2026
Autophagolysosomal exocytosis inverts Src kinase onto the cell surface in cancerCorleone S Delaveris, Rita P Loudermilk, Apurva Pandey, et al.
Cell Reports|December 21, 2022
Genomic heterogeneity as a barrier to precision oncology in urothelial cancerTimothy N Clinton, Ziyu Chen, Hannah Wise, et al.
Nature Communications|September 10, 2025
Modulating the PPARγ pathway upregulates NECTIN4 and enhances chimeric antigen receptor (CAR) T cell therapy in bladder cancerKevin Chang, Henry M Delavan, Elizabeth Yip, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 8, 2025
Impaired CAMK4 Activity Limits Atherosclerosis and Reprograms MyelopoiesisAzuah L Gonzalez, Cristina M Youwakim, Brenda F Leake, et al.
European Urology|April 27, 2025
Clinical Outcomes, Genomic Heterogeneity, and Therapeutic Considerations Across Histologic Subtypes of Urothelial CarcinomaCarissa E Chu, Ziyu Chen, Karissa Whiting, et al.
JCO Precision Oncology|May 1, 2024
Natural History and Genomic Landscape of Chemotherapy-Resistant Muscle-Invasive Bladder CancerAndrew T Lenis, Karissa Whiting, Vignesh Ravichandran, et al.
Pageof 22